Home Cart Sign in  
Chemical Structure| 149908-53-2 Chemical Structure| 149908-53-2

Structure of Azimilide
CAS No.: 149908-53-2

Chemical Structure| 149908-53-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Azimilide is a class III antiarrhythmic compound, inhibits I(Ks) and I(Kr) in guinea-pig cardiac myocytes and I(Ks) (minK) channels expressed in Xenopus oocytes.

Synonyms: NE-10064

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Azimilide

CAS No. :149908-53-2
Formula : C23H28ClN5O3
M.W : 457.95
SMILES Code : O=C1N(CCCCN2CCN(C)CC2)C(CN1/N=C/C3=CC=C(C4=CC=C(Cl)C=C4)O3)=O
Synonyms :
NE-10064
MDL No. :MFCD00867099

Safety of Azimilide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
cells from the epicardial border zone (EBZ) of the 5-day-infarcted canine heart (IZs) 10 µM 5 s To study the effect of isoproterenol on IKs, results showed that in some IZs, isoproterenol-stimulated azimilide-sensitive currents exhibited fast activation and large amplitude Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H667-73
normal canine ventricular cells (NZs) 10 µM 5 s To study the effect of isoproterenol on IKs, results showed that isoproterenol significantly increased IKs tail current density Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H667-73
mouse pancreatic β-cells 3 μM 5 min To investigate the inhibitory effect of Azimilide on Kslow current, results showed that Azimilide reversibly suppressed Kslow current, reducing current density from 1.68 ± 0.31 to 0.77 ± 0.15 pA/pF. J Gen Physiol. 2005 Oct;126(4):353-63

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00035490 Arrhythmia Phase 3 Completed - -
NCT00035451 Atrial Fibrillation Phase 3 Completed - -
NCT01097330 Defibrillators, Implantable ... More >> Tachycardia, Ventricular Less << Phase 3 Terminated(Anticipated non-fea... More >>sibility of recruitment objectives) Less << December 2014 United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Cardiac Arrhythmia Research Foundation Austin, Texas, United States, 78705 United States, Virginia University of Virginia Health System Charlottesville, Virginia, United States, 22908 Canada, Ontario Hamilton Health Sciences Hamilton, Ontario, Canada, L8L 2X2 Southlake Regional Health Centre Newmarket, Ontario, Canada, L3Y 2P9 University of Ottawa Heart Institute Ottawa, Ontario, Canada, K1Y 4W7 Canada, Quebec McGill University Health Center Montreal, Quebec, Canada, H3G 1A4 Canada Institut Universitaire de Cardiologie et Pneumologie de Québec Quebec, Canada, G1V 4G5 China Beijng Fuwai Heart Hospital Beijing, China, 100037 Less <<
NCT00752596 Congestive Heart Failure Phase 2 Completed - United States, Arizona ... More >> Research Site Scottsdale, Arizona, United States, 85251 Less <<
NCT00035477 Atrial Fibrillation Phase 3 Completed - -
NCT00035464 Atrial Fibrillation Phase 3 Completed - -
NCT01464476 Arrhythmias, Cardiac ... More >> Heart Diseases Cardiovascular Diseases Implantable Cardioverter Defibrillator Less << Phase 3 Terminated June 2013 -
NCT00318838 Healthy Phase 1 Completed - United States, Maryland ... More >> Parexel CPRU, Harbor Hospital Center Baltimore, Maryland, United States, 21225 Less <<
NCT00751738 Arrhythmias Phase 3 Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.18mL

0.44mL

0.22mL

10.92mL

2.18mL

1.09mL

21.84mL

4.37mL

2.18mL

References

 

Historical Records

Categories